A detailed history of Voloridge Investment Management, LLC transactions in Insmed Inc stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 738,951 shares of INSM stock, worth $52.1 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
738,951
Previous 922,002 19.85%
Holding current value
$52.1 Million
Previous $61.8 Million 12.68%
% of portfolio
0.21%
Previous 0.24%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$62.0 - $79.01 $11.3 Million - $14.5 Million
-183,051 Reduced 19.85%
738,951 $53.9 Million
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $19.1 Million - $60.4 Million
866,276 Added 1554.53%
922,002 $61.8 Million
Q1 2024

May 15, 2024

SELL
$25.72 - $29.94 $844,104 - $982,600
-32,819 Reduced 37.06%
55,726 $1.51 Million
Q4 2023

Feb 14, 2024

SELL
$23.42 - $31.74 $412,660 - $559,258
-17,620 Reduced 16.6%
88,545 $2.74 Million
Q3 2023

Nov 14, 2023

BUY
$19.86 - $26.93 $1.79 Million - $2.43 Million
90,121 Added 561.71%
106,165 $2.68 Million
Q2 2023

Aug 14, 2023

BUY
$16.44 - $21.1 $263,763 - $338,528
16,044 New
16,044 $338,000
Q3 2022

Nov 14, 2022

SELL
$20.88 - $28.21 $29,816 - $40,283
-1,428 Reduced 3.24%
42,691 $920,000
Q2 2022

Aug 15, 2022

BUY
$17.07 - $25.71 $61,912 - $93,250
3,627 Added 8.96%
44,119 $870,000
Q1 2022

May 16, 2022

BUY
$20.42 - $28.13 $826,846 - $1.14 Million
40,492 New
40,492 $952,000
Q4 2020

Feb 16, 2021

SELL
$31.45 - $40.54 $884,594 - $1.14 Million
-28,127 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$26.0 - $34.5 $731,302 - $970,381
28,127 New
28,127 $904,000
Q3 2019

Nov 14, 2019

SELL
$15.49 - $25.78 $142,786 - $237,640
-9,218 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$23.0 - $32.19 $546,480 - $764,834
-23,760 Reduced 72.05%
9,218 $236,000
Q1 2019

May 15, 2019

BUY
$13.91 - $31.15 $458,723 - $1.03 Million
32,978 New
32,978 $959,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.56B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.